Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Open in API
Filings indexed 1,190 across all filing types
Latest filing 2023-10-25 Call Transcript
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 70% confidence The document is a notification about an upcoming earnings call to discuss the un-audited financial results for the quarter and half-year ended September 30, 2023. It includes details about the date, time, speakers, and dial-in information for the call. There is no actual financial data or detailed financial report included in the text. The document serves as an announcement for the earnings call rather than the earnings release itself or the call transcript. Therefore, it fits best under the category of Call Transcript (CT) as it relates directly to the earnings call event, but since it is only an announcement of the call and not the transcript, the closest appropriate classification is Call Transcript (CT) with moderate confidence.
2023-10-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is a notification about an upcoming earnings call to discuss the un-audited financial results for the quarter and half-year ended September 30, 2023. It includes details about the date, time, speakers, and dial-in information for the call. There is no actual financial data or results presented in this document, only an announcement of the call event. According to the classification rules, such a document is best classified as a Call Transcript (CT) category, as it relates to the earnings call event. However, since this is only an announcement of the earnings call and not the transcript itself, it is not a transcript but an announcement of the call. The closest fitting category is Call Transcript (CT) because it is about the earnings call, but since it is only an announcement, the best fit is still CT as no other category fits better. Confidence is high due to clear mention of earnings call and no financial data present.
2023-10-24 English
Board Meeting — STRIDES PHARMA SCIENCE LIMITED has informed the Exchange about Board Meeting to be held on 30-Oct-2023 to inter-alia consider and approve the Unaudited Financial results of the Compan…
Regulatory Filings
2023-10-20 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short announcement informing stock exchanges about an upcoming Board Meeting scheduled to approve unaudited financial results for a quarter and half year period. It references Regulation 29 of SEBI Listing Regulations, which pertains to disclosures about Board meetings. The document does not contain any financial data or results itself, only a notice of the meeting date and related procedural information. The length is only 1255 characters, indicating it is a brief announcement rather than a full report. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not fit into other specific categories like Interim Report or Board/Management Information (which usually involves changes in personnel).
2023-10-20 English
Allotment of Securities
Share Issue/Capital Change Classification · 100% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the allotment of equity shares upon conversion of warrants. It references SEBI regulations and circulars related to disclosure requirements for listed companies. The content details the increase in paid-up share capital due to the allotment of shares, the type of securities issued, the number of shares, the issue price, and the investor involved. This is a clear announcement of a capital change event, specifically the issuance of new shares following warrant conversion. The document is relatively short (3842 characters) and does not contain financial statements or detailed financial analysis, but rather a regulatory disclosure about share capital changes. Therefore, it fits best under the category of Share Issue/Capital Change (SHA).
2023-10-20 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing the USFDA approval of a pharmaceutical product by Strides Pharma Science Limited. It is dated October 4, 2023, and contains no financial statements, regulatory certifications, or detailed financial data. The content focuses on product approval news and company background, typical of a press release. The document length is 4338 characters, which is relatively short and consistent with a press release rather than a detailed financial or regulatory filing. There is no indication that this is an Annual Report, Earnings Release, or any other detailed financial or regulatory document. Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements and press releases that do not fit other categories.
2023-10-04 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.